Thirty years after Dolly the sheep, the first cloned mammal, was born, cloning technology has evolved beyond simple replication. While Dolly's creation sparked speculation about cloned pets, humans, and extinct species revival, modern cloning is a complex biotech tool used to study diseases, aid conservation, and advance regenerative medicine. The process involves somatic cell nuclear transfer, where a donor cell's nucleus replaces an egg's nucleus, leading to an embryo genetically identical to the donor. However, cloning remains inefficient, requiring specialized resources and facing challenges like incomplete epigenetic reprogramming. Despite these hurdles, research has led to breakthroughs such as induced pluripotent stem cells, which allow adult cells to be reprogrammed for medical applications without creating entire organisms.
Bias read (Center): The article presents a factual overview of cloning technology's development and current uses without overt ideological slant. It discusses scientific processes, historical milestones, and potential applications neutrally, focusing on technical challenges and breakthroughs rather than advocating for,




